This unique characteristic positions OX1R as a promising candidate for therapeutic intervention, with OX1R agonists potentially enhancing the efficacy of traditional chemotherapy treatments in colon cancer (Wolpin and Mayer, 2008; Segal and Saltz, 2009). The gene discussed is HCRTR1; the disease is malignant colon neoplasm.